Transitory tyrosinaemia of newborn (Q45883): Difference between revisions
From determinar.ia.br - Determine suas informações
Created a new Item |
Changed an Item |
||||||||||||||
| (7 intermediate revisions by the same user not shown) | |||||||||||||||
| description / pt-br | description / pt-br | ||||||||||||||
Níveis elevados de tirosina no sangue, clinicamente assintomático, causado por maturação fetal tardia da 4-hidroxifenilpiruvato dioxigenase, geralmente detectado no exame de rastreamento neonatal. Mais comumente observada em bebês prematuros recebendo fórmulas lácteas com alto teor de proteína. Geralmente considerado benigno, ocorre remissão por volta das 4-6 semanas de vida. | |||||||||||||||
| description / en | description / en | ||||||||||||||
Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age. | |||||||||||||||
| Property / Canonical URI | |||||||||||||||
| Property / Canonical URI: https://id.who.int/icd/entity/25668130 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / CURIE | |||||||||||||||
CID11:KB63.4 | |||||||||||||||
| Property / CURIE: CID11:KB63.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Canary Token | |||||||||||||||
dki-india-KB63.4 | |||||||||||||||
| Property / Canary Token: dki-india-KB63.4 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Verification Status | |||||||||||||||
Concluído | |||||||||||||||
| Property / Verification Status: Concluído / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Knowledge Architect | |||||||||||||||
| Property / Knowledge Architect: https://pauloleads.com.br/cases-publicos/ / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Collection date | |||||||||||||||
13 August 2026
| |||||||||||||||
| Property / Collection date: 13 August 2026 / rank | |||||||||||||||
Normal rank | |||||||||||||||
| Property / Linked ICD 10 | |||||||||||||||
| Property / Linked ICD 10: P74.5 / rank | |||||||||||||||
Normal rank | |||||||||||||||
Latest revision as of 14:08, 13 August 2026
Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age.
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | KB63.4 |
||
| English | Transitory tyrosinaemia of newborn |
Clinically asymptomatic elevated blood tyrosine level caused by late fetal maturation of 4-hydroxyphenylpyruvate dioxygenase, usually detected on newborn bloodspot screening. Most commonly seen in premature infants receiving milk formulae with high protein content. Generally considered benign and resolves by 4-6 weeks of age. |
Statements
CID11:KB63.4
0 references
dki-india-KB63.4
0 references
Concluído
0 references
13 August 2026
0 references
